BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 38481246)

  • 1. Energy balance in congenital generalized lipodystrophy type I.
    Taleban S; Carew HT; Dichek HL; Deeb SS; Hollenback D; Weigle DS; Cummings DE; Brunzell JD
    Metabolism; 2008 Aug; 57(8):1155-61. PubMed ID: 18640396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary disease of adipose tissue: When to think about and how to evaluate it in clinical practice?
    Vatier C; Vigouroux C; Mosbah H
    Ann Endocrinol (Paris); 2024 Jun; 85(3):190-194. PubMed ID: 38871502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of stopping and restarting leptin in an adolescent with lipodystrophy.
    Kamran F; Rother KI; Cochran E; Safar Zadeh E; Gorden P; Brown RJ
    Horm Res Paediatr; 2012; 78(5-6):320-5. PubMed ID: 22965160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Checkpoint Inhibitors-Associated Generalized Lipodystrophy: Reconstructive Challenges of an Emerging and Distinct Form of Lipodystrophy.
    Kreutz-Rodrigues L; Cherukuri S; Rames JD; Chen A; Meira Pazelli A; Mardini S; Gibreel W
    J Craniofac Surg; 2024 Jun; ():. PubMed ID: 38869298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features of BSCL2 related congenital generalized lipodystrophy in China: long-term follow-up of three patients and literature review.
    Su X; Lin Y; Liu L; Mei H; Xu A; Zeng C; Sheng H; Cheng J; Shao Y; Zheng R; Ting TH; Zhang W; Li X
    J Pediatr Endocrinol Metab; 2023 Jan; 36(1):74-80. PubMed ID: 36433712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease.
    Hussain I; Patni N; Garg A
    Pathology; 2019 Feb; 51(2):202-212. PubMed ID: 30595509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of disease characteristics of a large patient cohort with congenital generalized lipodystrophy from the Middle East and North Africa.
    Al Yaarubi S; Alsagheir A; Al Shidhani A; Alzelaye S; Alghazir N; Brema I; Alsaffar H; Al Dubayee M; Alshahrani A; Abdelmeguid Y; Omar OM; Attia N; Al Amiri E; Al Jubeh J; Algethami A; Alkhayyat H; Haleem A; Al Yahyaei M; Khochtali I; Babli S; Nugud A; Thalange N; Albalushi S; Hergli N; Deeb A; Alfadhel M
    Orphanet J Rare Dis; 2024 Mar; 19(1):118. PubMed ID: 38481246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural History of Congenital Generalized Lipodystrophy: A Nationwide Study From Turkey.
    Akinci B; Onay H; Demir T; Ozen S; Kayserili H; Akinci G; Nur B; Tuysuz B; Nuri Ozbek M; Gungor A; Yildirim Simsir I; Altay C; Demir L; Simsek E; Atmaca M; Topaloglu H; Bilen H; Atmaca H; Atik T; Cavdar U; Altunoglu U; Aslanger A; Mihci E; Secil M; Saygili F; Comlekci A; Garg A
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2759-67. PubMed ID: 27144933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability.
    Simha V; Agarwal AK; Aronin PA; Iannaccone ST; Garg A
    Am J Med Genet A; 2008 Sep; 146A(18):2318-26. PubMed ID: 18698612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital generalized lipodystrophy: The evaluation of clinical follow-up findings in a series of five patients with type 1 and two patients with type 4.
    Nilay Güneş ; Kutlu T; Tekant GT; Eroğlu AG; Üstündağ NÇ; Öztürk B; Onay H; Tüysüz B
    Eur J Med Genet; 2020 Apr; 63(4):103819. PubMed ID: 31778856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying congenital generalized lipodystrophy using deep learning-DEEPLIPO.
    da Cunha Olegario NB; da Cunha Neto JS; Barbosa PCS; Pinheiro PR; Landim PLA; Montenegro APDR; Fernandes VO; de Albuquerque VHC; Duarte JBF; da Cruz Paiva Lima GE; Junior RMM
    Sci Rep; 2023 Feb; 13(1):2176. PubMed ID: 36750605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital generalized lipodystrophy in Taiwan.
    Hsu RH; Lin WD; Chao MC; Hsiao HP; Wong SL; Chiu PC; Chu SY; Ke YY; Lau BH; Chien YH; Hwu WL; Tsai FJ; Wang CH; Lee NC
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):142-147. PubMed ID: 29478747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial Screening for the Prevention of Rare Diseases: A Focus on Lipodystrophy in Southern Saudi Arabia.
    Abuzenadah A; Alganmi N; AlQurashi R; Hawsa E; AlOtibi A; Hummadi A; Nahari AA; AlZelaye S; Aljuhani NR; Al-Attas M; Abusamra H; Turkistany S; Karim S; Mirza Z; Al-Qahtani M; Chaudhary A; Al Eissa MM
    J Epidemiol Glob Health; 2024 Mar; 14(1):162-168. PubMed ID: 38231342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain.
    Fernández-Pombo A; Sánchez-Iglesias S; Castro-Pais AI; Ginzo-Villamayor MJ; Cobelo-Gómez S; Prado-Moraña T; Díaz-López EJ; Casanueva FF; Loidi L; Araújo-Vilar D
    Front Endocrinol (Lausanne); 2023; 14():1250203. PubMed ID: 38034001
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.